Form 4: USANA Health Sciences Director Acquires Restricted Stock Units

John Turman Fleming, a director at USANA Health Sciences, acquired 4,230 restricted stock units on May 20, 2025, according to a Form 4 filing.

Summary

• On May 20, 2025, John Turman Fleming, a director of USANA Health Sciences, acquired 4,230 restricted stock units.
• Each restricted stock unit represents a contingent right to receive one share of USANA common stock.
• The restricted stock units vest in four equal installments: 25% on July 24, 2025, October 23, 2025, January 22, 2026, and April 23, 2026.
• Following the transaction, Fleming directly owns 4,230 derivative securities.

Sentiment

Score: 5

Explanation: The document is a routine regulatory filing related to stock grants, indicating a neutral sentiment.

Future Outlook

The vesting schedule indicates a staggered release of shares into the market over the next year, which could have a minor impact on stock supply.

Industry Context

Director stock grants are a common practice in publicly traded companies to align management's interests with those of shareholders.

Comparison to Industry Standards

• Stock grants to directors are a typical component of compensation packages in the health and wellness industry.
• Companies like Herbalife and Nu Skin also utilize stock-based compensation to incentivize their leadership.
• The vesting schedule is fairly standard, aligning with typical industry practices for retaining key personnel.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder confidence by demonstrating the director's commitment to the company's long-term success.
• Employees may view the stock grant as a positive sign of the company's financial health and stability.

Key Dates

Keywords

USANA Health Sciences, Director, Restricted Stock Units, Form 4, Beneficial Ownership, USNA, Fleming